ID
16302
Beschrijving
Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193206
Link
https://clinicaltrials.gov/show/NCT00193206
Trefwoorden
Versies (1)
- 10-07-16 10-07-16 -
Geüploaded op
10 juli 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00193206
Eligibility Breast Cancer NCT00193206
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Exclusion Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C0680251
Beschrijving
pregnant or breast feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
heart disease with congestive heart failure
Datatype
boolean
Alias
- UMLS CUI [1]
- C0018802
Beschrijving
Myocardial Infarction
Datatype
boolean
Alias
- UMLS CUI [1]
- C0027051
Beschrijving
prior chemotherapy or hormone therapy for breast cancer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514457
- UMLS CUI [1,2]
- C1514460
- UMLS CUI [1,3]
- C0678222
Beschrijving
active uncontrolled infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
Beschrijving
Additional Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1516637
Similar models
Eligibility Breast Cancer NCT00193206
- StudyEvent: Eligibility
C0278601 (UMLS CUI [1,2])
C0677984 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0193867 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C1514460 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])